Clinical, Scintigraphic, and Histologic Findings
| Intensity of 18F-FDG uptake determined by: | Pathologic or FU findings | ||||||
|---|---|---|---|---|---|---|---|
| Lesion | Size on CT (mm) | Location | Visual analysis | SUV | CR | FU period (mo) | |
| 1 | 13 | RML | Faint | 1.25 | 0.16 | Adenoca (well) | — |
| 2 | 14 | LUL | Faint | 1.61 | 0.37 | Adenoca (well) | — |
| 3 | 15 | RUL | Moderate | 2.08 | 0.49 | Adenoca (well) | — |
| 4 | 16 | LLL | Faint | 1.69 | 0.21 | Adenoca (well) | — |
| 5 | 17 | LLL | Faint | 1.92 | 0.48 | Adenoca (well) | — |
| 6 | 20 | RLL | Moderate | 1.64 | 0.45 | Adenoca (well) | — |
| 7 | 20 | RLL | Moderate | 2.18 | 0.29 | Adenoca (well) | — |
| 8 | 32 | RUL | Moderate | 2.29 | 0.39 | Adenoca (well) | — |
| 9 | 10 | LUL | Moderate | 1.51 | 0.36 | Adenoca (mod) | — |
| 10 | 12 | LLL | Faint | 2.01 | 0.36 | Adenoca (mod) | — |
| 11 | 15 | RLL | Moderate | 2.20 | 0.39 | Adenoca (mod) | — |
| 12 | 15 | LUL | Moderate | 1.74 | 0.43 | Adenoca (mod) | — |
| 13 | 16 | LLL | Faint | 0.97 | 0.09 | Adenoca (mod) | — |
| 14 | 10 | LLL | Faint | 1.69 | 0.32 | Squamous cell ca | — |
| 15 | 8 | RUL | Faint | 1.60 | 0.18 | Small cell ca | — |
| 16 | 14 | RLL | Faint | 1.64 | 0.29 | Large cell ca | — |
| 17 | 12 | LLL | Absent | 1.52 | 0.16 | Hamartoma | — |
| 18 | 28 | RML | Absent | 0.90 | 0.03 | Hamartoma | — |
| 19 | 8 | RUL | Absent | 1.25 | −0.02 | Tuberculoma | — |
| 20 | 8 | RUL | Faint | 2.11 | 0.28 | Tuberculoma | — |
| 21 | 12 | RUL | Faint | 0.69 | −0.01 | Tuberculoma | — |
| 22 | 15 | LUL | Moderate | 1.88 | 0.42 | Tuberculoma | — |
| 23 | 25 | RUL | Moderate | 1.58 | 0.30 | Tuberculoma | — |
| 24 | 14 | LLL | Absent | 1.41 | 0.25 | FU (disappearance) | 3 |
| 25 | 15 | LLL | Absent | 1.05 | 0.17 | FU (disappearance) | 14 |
| 26 | 21 | LUL | Absent | 1.28 | 0.27 | FU (disappearance) | 17 |
| 27 | 9 | RML | Absent | 1.31 | 0.09 | FU (decrease) | 13 |
| 28 | 10 | RLL | Faint | 1.55 | 0.26 | FU (decrease) | 19 |
| 29 | 12 | RML | Absent | 0.65 | −0.18 | FU (decrease) | 19 |
| 30 | 12 | RML | Absent | 0.81 | 0.00 | FU (decrease) | 20 |
| 31 | 15 | LUL | Absent | 1.13 | 0.37 | FU (decrease) | 21 |
| 32 | 15 | RLL | Absent | 1.59 | 0.24 | FU (decrease) | 13 |
| 33 | 33 | LLL | Moderate | 2.31 | 0.36 | FU (decrease) | 6 |
| 34 | 7 | RLL | Faint | 1.39 | 0.21 | FU (no change) | 13 |
| 35 | 9 | RUL | Absent | 1.22 | 0.13 | FU (no change) | 16 |
| 36 | 9 | RLL | Absent | 0.96 | −0.02 | FU (no change) | 12 |
| 37 | 10 | RML | Absent | 1.27 | 0.15 | FU (no change) | 16 |
| 38 | 12 | RUL | Faint | 1.39 | 0.11 | FU (no change) | 21 |
| 39 | 15 | RUL | Absent | 1.05 | −0.04 | FU (no change) | 24 |
| 40 | 15 | RML | Absent | 0.95 | 0.08 | FU (no change) | 21 |
| 41 | 16 | RUL | Faint | 1.95 | 0.31 | FU (no change) | 6 |
| 42 | 17 | RUL | Faint | 1.45 | 0.29 | FU (no change) | 12 |
| 43 | 36 | RLL | Absent | 1.51 | 0.17 | FU (no change) | 16 |
FU = follow-up; RML = right middle lung; adenoca = adenocarcinoma; well = well differentiated; —, no follow-up data; LUL = left upper lung; RUL= right upper lung; LLL = left lower lung; RLL = right lower lung; mod = moderately differentiated; ca = carcinoma.